TNF-a and IL-10 control macrophage expression of CXCL13, a prognostic biomarker of idiopathic pulmonary fibrosis
N. Bellamri (Rennes, France), C. Rousseau (Rennes, France), C. Morzadec (Rennes, France), M. Le Garrec (Rennes, France), B. Arnouat (Rennes, France), A. Joannes (Rennes, France), B. De La Latour (Rennes, France), F. Llamas-Guttierez (Rennes, France), L. VERNHET (Rennes, France), S. Jouneau (Rennes, France)
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Bellamri (Rennes, France), C. Rousseau (Rennes, France), C. Morzadec (Rennes, France), M. Le Garrec (Rennes, France), B. Arnouat (Rennes, France), A. Joannes (Rennes, France), B. De La Latour (Rennes, France), F. Llamas-Guttierez (Rennes, France), L. VERNHET (Rennes, France), S. Jouneau (Rennes, France). TNF-a and IL-10 control macrophage expression of CXCL13, a prognostic biomarker of idiopathic pulmonary fibrosis. 4812
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006
Decreased levels of CXC angiogenic chemokines (IL-8, ENA-78 and GRO-α) in BALF after interferon gamma-1b treatment in IPF patients Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005
CTGF and TNFa expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis before and after treatment with azathioprine and interferon-g Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009
TNF-alpha, IL-8, IL-6 levels in serum of sarcoidosis patients with different clinical course Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
IL-6 and IL-8 in stable and exacerbated IPF patients and their association to outcome Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016
Serum levels of IL-10 and IL-12 i patients with pulmonary sarcoidosis Source: Annual Congress 2009 - Inflammation and airways Year: 2009
CCL22 and CCL17 in rat radiation pneumonitis and in human idiopathic pulmonary fibrosis Source: Eur Respir J 2004; 24: 49-56 Year: 2004
Serum levels of IL-10 and IL-12p40 in pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 139s Year: 2007
The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008
Interleukin-18, interleukin-12, interferon γ and interleukin-18 receptor expression is decreased in the recovery phase of pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 366s Year: 2001
Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005
Inflammatory and regulatory cytokine IL-6 in plasma and BAL fluid of patients with pulmonary sarcoidosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Prognostic values of serum IP-10 and IL-17 in patients with pulmonary tuberculosis Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011
Relationship between IL-8, IL-10, MMP-9 and morphological findings in BAL fluid of patients with interstitial lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 225s Year: 2003
IL-18 and IL-12 induce inflammatory cytokines, chemokine ligand 9 (CXCL9) and T cell infiltration in pulmonary tissue Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006
CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 701-707 Year: 2005
Association between proinflammatory cytokines (TNFa and IL8) and fibrinolytic system in malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 494s Year: 2004
Expression of mRNA of selected inflammatory markers in BALf cells from patients with sarcoidosis and idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017
Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004